CFDB - Cystic Fibrosis DataBase

Prospective validation and clinical evaluation of a new posaconazole dosing regimen for children and adolescents with cystic fibrosis and Aspergillus infection.

ongoing trials  trial from other registries

Details
  • 2019

Acceptance and Commitment Therapy vs. Supportive Psychotherapy With Cystic Fibrosis Patients - Recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2019
  • Drexel University

Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis - Phase 4 - Not yet recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2019
  • Emory University

Feasibility of a New Model for Exercise Prescription in Cystic Fibrosis - Not yet recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2019
  • University of Alabama at Birmingham

Ancillary Home Airway Clearance in CF Patients ( HomeCareSIMEOX ) - Not yet recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2019
  • Physio-Assist|Icadom

Home Airway Clearance in CF Patients - Not yet recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2019
  • Physio-Assist|Icadom

Efficacy of Simeox Airway Clearance Therapy in Children With Cystic Fibrosis - Not yet recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2019
  • Physio-Assist

Modeling of Chest Physiotherapy Using Impedance Measurements (PHYSIOMOD) - Recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2019
  • Assistance Publique - Hôpitaux de Paris

A 4-week Study to Test Different Doses of BI 1265162 in Adolescents and Adults With Cystic Fibrosis Using the Respimat® Inhaler - Phase 2 - Not yet recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2019
  • Boehringer Ingelheim

A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes) - Phase 3 - Not yet recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2019
  • Vertex Pharmaceuticals Incorporated